Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT00685529 · COMPLETED
Trial details
- NCT number
- NCT00685529
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2005-10-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.